Stuart Rich
2021
In 2021, Stuart Rich earned a total compensation of $818.3K as Chief Medical Officer at Tenax Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $115,000 |
|---|---|
| Option Awards | $402,789 |
| Salary | $287,500 |
| Other | $13,026 |
| Total | $818,315 |
Rich received $402.8K in option awards, accounting for 49% of the total pay in 2021.
Rich also received $115K in non-equity incentive plan, $287.5K in salary and $13K in other compensation.
Rankings
In 2021, Stuart Rich's compensation ranked 9,419th out of 12,406 executives tracked by ExecPay. In other words, Rich earned more than 24.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,419 out of 12,406 | 24th |
Division Manufacturing | 4,169 out of 5,494 | 24th |
Major group Chemicals And Allied Products | 1,843 out of 2,369 | 22nd |
Industry group Drugs | 1,635 out of 2,090 | 22nd |
Industry Pharmaceutical Preparations | 1,213 out of 1,537 | 21st |
Source: SEC filing on April 28, 2022.
Rich's colleagues
We found four more compensation records of executives who worked with Stuart Rich at Tenax Therapeutics in 2021.